Arsanis Secures $12,999,999 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01fa6721-91bc-4f8b-b590-9669b0cb4482
Date
8/13/2013
Company Name
Arsanis
Mailing Address
16 Cavendish Court Lebanon, NH 03766
Company Description
Arsanis is committed to the development of fully human monoclonal antibodies against severe infectious diseases for which current prophylactic or therapeutic approaches are ineffective or non-existent.
Website
http://www.arsanis.com
Transaction Type
Venture Equity
Transaction Amount
$12,999,999
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed